Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 10Thoracic 1Gynecologic 1Gastrointestinal 1

Conditions

Esophageal Neoplasms 72Esophageal Squamous Cell Carcinoma 41Carcinoma, Non-Small-Cell Lung 32Stomach Neoplasms 31Colorectal Neoplasms 29Ovarian Neoplasms 25Pancreatic Neoplasms 21Adenocarcinoma Of Esophagus 16Breast Neoplasms 15Lung Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Sarcoma 10Neoplasm Metastasis 10Melanoma 10Liver Neoplasms 10Endometrial Neoplasms 10Colonic Neoplasms 9Neoplasms 8Hepatoblastoma 8Head and Neck Neoplasms 8Cholangiocarcinoma 8Carcinoma, Hepatocellular 8Uterine Cervical Neoplasms 7Urinary Bladder Neoplasms 7Triple Negative Breast Neoplasms 7Carcinoma, Renal Cell 7Anus Neoplasms 7Rectal Neoplasms 6Carcinoma, Squamous Cell 6Testicular Neoplasms 5

Interventions

aflibercept 2Trastuzumab 2trastuzumab deruxtecan 1tipifarnib 1pembrolizumab 1entinostat 1Thalidomide 1Ramucirumab 1Radiotherapy 1Nivolumab 1Methods 1Lenalidomide 1Interleukin-12 Subunit p35 1Interleukin-12 1Gemcitabine 1Fentanyl 1Early Intervention, Educational 1Docetaxel 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urethral Neoplasms × Carboplatin × Gastrointestinal × Clear all
NCT01352962 2026-04-14

Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
18 enrolled
GastrointestinalGenitourinaryGynecologicThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Pancreatic Neoplasms, Ureteral Neoplasms, Urethral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡